BioSpace News Archive

Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that the Company has agreed with Kancera to take over Kancera’s drug development facility in Solna, Sweden . The agreement is an important step in the development of Oncopeptides’ pre-clinical operations and marks an additional reinforcement of the Company’s research capacity

The Phase 2/3 multi-center, randomized, double-blind, parallel-arm, placebo-controlled study with opaganib aims to enroll 270 severe COVID-19 patients in up to 40 clinical sites across the UK, Italy, Russia and additional countries -- In parallel, a U.S. study with opaganib in up to 40 severe COVID-19 patients has been initiated at leading medical centers TEL-AVIV, Israel and RALEIGH, N.C., June 29, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (“RedHill” or

GTCR, a leading private equity firm, announced today that its Cedar Gate Technologies (“Cedar Gate”) management partnership with CEO David Snow has acquired Citra Health Solutions (“Citra”). Citra sells a specialty workflow software solution

American Diabetes Association, Black Lives Matter, NAACP, AARP and others urge Congress to make testing more accessible through mobile units, community health workers and other means

ReNeuron Group plc (AIM:RENE), a global leader in the development of cell-based therapeutics, is pleased to announce further positive long-term data from the ongoing Phase 2a clinical trial of its hRPC stem cell therapy candidate in retinitis pigmentosa (RP)

Hillrom (NYSE: HRC) will host its fiscal third quarter 2020 earnings conference call and webcast on Friday, July 31, 2020, beginning at 7:30 a.m. (CT) / 8:30 a.m. (ET).

Acceleron Pharma Inc., a leading biopharmaceutical company in the discovery, development and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced that it intends to offer and sell, subject to market and other conditions, $400 million of its common stock in an underwritten public offering.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced the promotions of Brian R. Mueller to Executive Vice President, Chief Financial Officer and of Andrea L. Acosta to Group Vice President, Chief Accounting Officer.

NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, announced today the closing of its previously announced underwritten public offering of an aggregate of 8,521,500 shares of its common stock (4,811,500 shares at a price to the public of $9.50 per share and 3,710,000 shares at a price of $12.12 per share to NantKwest’s chairman,

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, announced today that it has joined the broad-market Russell 3000® Index at the conclusion of the 2020 Russell Indexes annual reconstitution, effective after the US market opened today.